BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175 | -43.4% | 3,500 | -28.6% | 0.00% | 0.0% |
| Q2 2023 | $309 | +5.1% | 4,900 | -25.8% | 0.00% | – |
| Q1 2023 | $294 | +254.2% | 6,600 | +247.4% | 0.00% | – |
| Q4 2022 | $83 | -100.0% | 1,900 | -67.8% | 0.00% | -100.0% |
| Q3 2022 | $388,000 | +92.1% | 5,900 | +47.5% | 0.00% | +100.0% |
| Q2 2022 | $202,000 | -54.1% | 4,000 | -42.0% | 0.00% | -50.0% |
| Q1 2022 | $440,000 | -40.5% | 6,900 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $739,000 | -5.4% | 6,900 | -9.2% | 0.00% | 0.0% |
| Q3 2021 | $781,000 | +5.8% | 7,600 | -9.5% | 0.00% | 0.0% |
| Q2 2021 | $738,000 | 0.0% | 8,400 | +10.5% | 0.00% | 0.0% |
| Q1 2021 | $738,000 | -55.5% | 7,600 | -48.6% | 0.00% | -50.0% |
| Q4 2020 | $1,659,000 | +148.7% | 14,800 | +105.6% | 0.01% | +100.0% |
| Q3 2020 | $667,000 | +4.4% | 7,200 | -12.2% | 0.00% | 0.0% |
| Q2 2020 | $639,000 | +43.9% | 8,200 | +7.9% | 0.00% | +50.0% |
| Q1 2020 | $444,000 | -0.9% | 7,600 | +35.7% | 0.00% | 0.0% |
| Q4 2019 | $448,000 | -58.7% | 5,600 | -62.2% | 0.00% | 0.0% |
| Q3 2019 | $1,086,000 | +55.6% | 14,800 | +100.0% | 0.00% | -33.3% |
| Q2 2019 | $698,000 | +89.7% | 7,400 | +60.9% | 0.00% | +50.0% |
| Q1 2019 | $368,000 | +120.4% | 4,600 | +48.4% | 0.00% | +100.0% |
| Q4 2018 | $167,000 | -37.0% | 3,100 | -8.8% | 0.00% | 0.0% |
| Q3 2018 | $265,000 | -35.7% | 3,400 | -47.7% | 0.00% | -50.0% |
| Q2 2018 | $412,000 | -23.8% | 6,500 | +10.2% | 0.00% | 0.0% |
| Q1 2018 | $541,000 | +84.0% | 5,900 | +51.3% | 0.00% | +100.0% |
| Q4 2017 | $294,000 | +83.8% | 3,900 | +69.6% | 0.00% | 0.0% |
| Q3 2017 | $160,000 | -86.2% | 2,300 | -90.0% | 0.00% | -80.0% |
| Q2 2017 | $1,160,000 | +43.0% | 22,900 | +12.8% | 0.01% | +25.0% |
| Q1 2017 | $811,000 | +4.5% | 20,300 | -26.7% | 0.00% | +33.3% |
| Q4 2016 | $776,000 | -0.3% | 27,700 | +5.7% | 0.00% | 0.0% |
| Q3 2016 | $778,000 | – | 26,200 | – | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2015 | $79,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |